15.13
前日終値:
$15.38
開ける:
$15.37
24時間の取引高:
193.21K
Relative Volume:
0.61
時価総額:
$546.84M
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-2.89%
1か月 パフォーマンス:
-21.69%
6か月 パフォーマンス:
-34.10%
1年 パフォーマンス:
+0.00%
Ceribell Inc Stock (CBLL) Company Profile
CBLL を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
CBLL
Ceribell Inc
|
15.13 | 555.88M | 0 | 0 | 0 | 0.00 |
![]()
ABT
Abbott Laboratories
|
126.54 | 218.59B | 43.11B | 13.98B | 6.66B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
106.14 | 157.13B | 18.49B | 2.51B | 2.72B | 1.68 |
![]()
SYK
Stryker Corp
|
403.53 | 151.59B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
92.94 | 118.29B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
80.00 | 44.46B | 5.69B | 4.15B | 623.10M | 6.95 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-06-24 | 開始されました | BTIG Research | Buy |
2025-04-04 | 開始されました | Ladenburg Thalmann | Buy |
2024-11-05 | 開始されました | BofA Securities | Buy |
2024-11-05 | 開始されました | Canaccord Genuity | Buy |
2024-11-05 | 開始されました | JP Morgan | Overweight |
2024-11-05 | 開始されました | TD Cowen | Buy |
2024-11-05 | 開始されました | William Blair | Outperform |
すべてを表示
Ceribell Inc (CBLL) 最新ニュース
What drives CeriBell Inc. stock priceMassive stock growth - PrintWeekIndia
What institutions are buying CeriBell Inc. stock nowFree Consultation - jammulinksnews.com
What analysts say about CeriBell Inc. stockAccelerated capital growth - PrintWeekIndia
Is CeriBell Inc. a good long term investmentAccelerated financial growth - Autocar Professional
CeriBell Inc. Stock Analysis and ForecastSuperior stock growth - jammulinksnews.com
Ceribell to Report Second Quarter 2025 Financial Results on August 5, 2025 - The Manila Times
How CeriBell Inc. stock performs during market volatilityReturn Optimized Trade Insights - Newser
Brokerages Set CeriBell, Inc. (NASDAQ:CBLL) Price Target at $32.14 - Defense World
What makes CeriBell Inc. stock price move sharplyFast Gains With Reduced Risk - Newser
Why CeriBell Inc. stock attracts strong analyst attentionWeekly Double Return List - Newser
CeriBell shares drop 38% following InvestingPro’s overvaluation warning By Investing.com - Investing.com South Africa
Ceribell sues Natus Medical for patent infringement - MSN
Ceribell, Inc.’s Strategic Positioning and Patent Strength Justify Buy Rating - TipRanks
Ceribell (CBLL) CEO Chao sells $442,500 in stock By Investing.com - Investing.com South Africa
Ceribell (CBLL) CEO Chao sells $442,500 in stock - Investing.com
Ceribell Inc (CBLL) 財務データ
Ceribell Inc (CBLL) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):